The Naughton treadmill protocol has become a popular treadmill test for use with patients with coronary artery disease (CAD). Frequently, the stages are reduced from 3 to 2 minutes, but there is little information on the prediction of aerobic capacity (AC) based on this abbreviated protocol. To determine the relationship between AC and exercise time (ET) with the modified Naughton protocol, 50 men with CAD, evenly divided between β blocked (β group) and non-β blocked patients (control group), completed a maximal graded exercise test with measurement of AC. These 50 patients were the validation group (VAL). An equation predicting AC, based on the VAL group, was calculated with stepwise regression equation using ET, β blocker usage did not significantly contribute to the regression model. The equation predicting AC from ET and age is: AC (ml ± kg-1 ± min-1) = 17.66 + ET (.985) -age (.169), r =.93, standard error of the estimate (SEE) = 3.2. A cross-validation (CV) group sample of 20 subjects (evenly divided between subjects taking β blockers and nonblocked subjects) completed the modified Naughton protocol, and was used to cross-validate the regression equation. The VAL group's equation was used to predict the CV group's AC, and this value was compared with the CV group's measured AC. The CV group's measured and predicted AC were not statistically different, indicating the appropriateness of the validation equation. Completing a given speed and grade with the shortened Naughton protocol yielded a lower AC than that predicted by the standard Naughton protocol. The results indicate that with trained patients with CAD: (1) AC can be predicted for clinical use from the modified Naughton protocol using E T and age, (2) minimal to moderate doses of β blocking medications did not alter the relationship between ET and AC, and (3) separate equations predicting AC are needed for the Naughton protocols with 3− and 2-minute stages.
Read full abstract